Clrb stock offering

Cellectar closes stock offering - Cellectar Biosciences ... Aug 26, 2014 · Cellectar Biosciences (CLRB) closed its public offering of 3,333,333 shares of common stock at $3.75 per share. The offering also included warrants …

View the latest Cellectar Biosciences Inc. (CLRB) stock price, news, historical charts, analyst ratings and financial information from WSJ. Dow Jones, a News Corp company. CLRB Stock Price, Forecast & News (Cellectar Biosciences) Cellectar Biosciences' stock was trading at $1.80 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLRB shares have decreased by 34.7% and is now trading at $1.1750. Cellectar Biosciences, Inc. (CLRB) Stock Analysis & News ...

CLRB Cellectar Biosciences Inc Securities Registration Statement (s-1) If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.

Cellectar Biosciences, Inc. Common Stock (CLRB) Stock ... Cellectar Biosciences, Inc. Common Stock (CLRB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. CLRB Stock Price | Cellectar Biosciences Inc. Stock Quote ... CLRB | Complete Cellectar Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ... Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing. Cellectar Biosciences, Inc. - CLRB - Stock Price Today - Zacks

Securities Registration Statement (s-1)

Cellectar Biosciences Makes Nasdaq Debut With $12.5M Stock Offering exchange today and is holding a public stock offering expected to raise $12.5 Capital Market under the ticker “CLRB Cellectar Biosciences Inc. - Company Profile - BCIQ Jan 25, 2020 · On Oct. 12, Cellectar Biosciences Inc. (NASDAQ:CLRB) raised $7.8 million through the sale of shares and convertible stock in a registered direct offering. Cellectar sold 2 million common shares at $1.87 and 41 preferred shares Thinking about buying stock in Cellectar Biosciences ... Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall

Jan 25, 2020 · On Oct. 12, Cellectar Biosciences Inc. (NASDAQ:CLRB) raised $7.8 million through the sale of shares and convertible stock in a registered direct offering. Cellectar sold 2 million common shares at $1.87 and 41 preferred shares

CLRB touched a 52-week high of $12.76 in intraday trading before closing at $7.38, down 1.47%. CytomX Therapeutics Inc. has completed its previously announced underwritten public offering of 5.1 million shares of its common stock at a price to the public of $24.50 each. The net proceeds from the offering were approximately $116.9 million. www.sec.gov Warrants to Purchase 5,333,356 Shares of Common Stock . We are offering 800,000 shares of common stock, together with warrants (the “Series C Warrants”) to purchase 800,000 shares of common stock at a purchase price of $1.50 (and the shares issuable from time to time upon exercise of the warrants) pursuant to this prospectus. Cellectar Announces $8M Stock Offering, Sending Shares Lower The Madison, WI-based biotech, which announced a $3.3 million stock offering in September 2015 and then said in April that it had raised $8 million from investors, now says it’s raising another INNT Innovate Biopharmaceuticals, Inc. — Stock Price and ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

21 Jan 2020 The analyst comments "CLRB is developing CLR 131, a targeted Shares of Cellectar Biosciences closed at $2.60 yesterday.

Based on analysts offering 12 month price targets for CLRB in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your Cellectar BioSciences, Inc. - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. CLRB - Cellectar Biosciences Summary, Stock ... - Benzinga

27 Jul 2018 July 27, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB) The offering is priced at a public offering price of $4.00 per common We are also offering to those purchasers, whose purchase of shares of  Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Cellectar Biosciences Inc have a median target of 6.40, with a high estimate of 10.00  CLRB Cellectar Biosciences, Inc. daily Stock Chart Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise